How AI Is Changing the Way We Analyse Blood Test Results

For decades, interpreting blood test results has followed a familiar pattern: a pathology lab analyses your sample, generates a report with reference ranges, and your GP reviews it during a brief consultation. If everything falls within the "normal" range, you are told you are fine. But this approach has significant limitations — and artificial intelligence is beginning to change everything.

The Limitations of Traditional Interpretation

The standard approach relies on population-based reference ranges derived from the central 95% of results in a "healthy" population. The problem is that "normal" does not mean "optimal." A fasting glucose of 5.8 mmol/L falls within the standard range but sits in the prediabetic zone. Furthermore, traditional interpretation looks at each marker in isolation, potentially missing patterns like emerging metabolic syndrome.

Time constraints compound the issue. The average GP consultation in Australia lasts approximately 15 minutes — limited time for a deep dive into the nuances of a comprehensive blood panel.

How AI Analyses Blood Tests Differently

AI blood test analysis works on fundamentally different principles. Machine learning algorithms trained on millions of results can identify subtle patterns that predict disease risk years before symptoms appear. A 2021 study in JAMA Network Open demonstrated that AI systems could predict the onset of type 2 diabetes up to five years before clinical diagnosis using routine blood data alone.

One of the most powerful capabilities is longitudinal pattern recognition. When you track results over multiple years, AI can detect gradual shifts — a slowly rising HbA1c, a declining eGFR, creeping inflammatory markers — that might be invisible in any single test. Each result might be "normal," but the trajectory tells a very different story.

Personalised Reference Ranges

Perhaps the most exciting development is the move towards personalised reference ranges. Research from the Weizmann Institute of Science has shown that individuals have remarkably stable personal baselines for many blood markers, and that deviations from your personal baseline are often more clinically meaningful than deviations from population-level ranges.

This is particularly relevant in Australia, where our diverse population means a one-size-fits-all reference range may not serve everyone equally well.

Current Applications in Australia

Several digital health platforms now allow Australians to upload their pathology results and receive AI-generated insights. These platforms use optical character recognition (OCR) to extract data from PDF pathology reports and apply machine learning models to analyse the results. The TGA and Australian Digital Health Agency are developing regulatory frameworks to ensure these systems meet rigorous standards.

The Future

Emerging research is exploring how AI can integrate blood test data with wearable device data, genetic information, and lifestyle factors to create comprehensive health risk profiles. Biological age estimation using combinations of routine blood markers is another rapidly developing field. For Australians interested in proactive health, AI blood test analysis offers an unprecedented opportunity to move beyond the binary "normal or abnormal" paradigm.

References

1. Ravaut M, et al. Development and validation of a machine learning model to predict onset of type 2 diabetes. JAMA Network Open. 2021;4(5):e2111315.
2. Segal E, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079–1094.
3. Levine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10(4):573–591.
4. Royal College of Pathologists of Australasia. Artificial Intelligence in Pathology: Position Statement. RCPA, Sydney, 2023.